Rüttimann S, Lavanchy J D, Meyer J L, Steinmann E
Medizinische Universitäts-Poliklinik, Departement für Innere Medizin, Kantonsspital, Basel.
Schweiz Med Wochenschr. 1988 Dec 10;118(49):1844-6.
From 1985 to 1987 101 patients infected with the human immunodeficiency virus (HIV) were seen at our outpatient clinic and prospectively analyzed in a cohort study. We evaluated the follow-up in 41 patients of CDC classes II and III with regard to the number of T-helper lymphocytes (T4) and clinical progression. The patients consisted of 24 i.v. drug addicts, 11 homosexuals and 6 persons with other or multiple risk factors for HIV infection. Patients with a T4 count of less than 400/mm3 at the first visit did not differ significantly with regard to development of AIDS from those with a count of greater than 400/mm3 after a mean follow-up of approximately 1 year. The course of the infection for the individual patient was extremely varied and not predictable by the T4 value. We conclude that the number of the T4-lymphocytes is of no help in assessment of prognosis in the individual patient of CDC classes II and III.
1985年至1987年期间,我们的门诊共接待了101例感染人类免疫缺陷病毒(HIV)的患者,并在一项队列研究中对其进行了前瞻性分析。我们评估了41例疾病控制中心(CDC)II级和III级患者的随访情况,涉及辅助性T淋巴细胞(T4)数量和临床进展。患者包括24名静脉注射吸毒者、11名同性恋者以及6名具有其他或多种HIV感染风险因素的人。初次就诊时T4细胞计数低于400/mm³的患者与计数高于400/mm³的患者在经过约1年的平均随访后,艾滋病的发展情况并无显著差异。个体患者的感染进程差异极大,无法通过T4值预测。我们得出结论,T4淋巴细胞数量对评估CDC II级和III级个体患者的预后并无帮助。